Jeonghee Cho

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Cell Proliferation

Top Venues

International journal of cancer

Pharmaceuticals (Basel, Switzerland)

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sang Ah Yi, Daseul Cho, Sujin Kim, Hyunjin Kim, Myung Kyung Choi, Hee Seong Choi, Sukjin Shin, Sujin Yun, Ahjin Lim, Jae Kyun Jeong, Da Eun Yoon, Hye Ji Cha, Kyoungmi Kim, Jeung-Whan Han, Hyun-Soo Cho, Jeonghee Cho
Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR). Molecular oncology (2024)
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, Jeong-Soo Park, Yeon Sun Seong
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, Yeon-Sun Seong
Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells. Cancers 13 (6) (2021)
Nayoung Kim, Daseul Cho, Hyunjin Kim, Sujin Kim, Young-Je Cha, Heidi Greulich, Adam Bass, Hyun-Soo Cho, Jeonghee Cho
Colorectal adenocarcinoma-derived EGFR mutants are oncogenic and sensitive to EGFR-targeted monoclonal antibodies, cetuximab and panitumumab. International journal of cancer 146 (8) (2019)
Jeonghee Cho, Sujin Kim, Jinyan Du, Matthew Meyerson
Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants. International journal of cancer 143 (3) (2018)